MediGuide's medical positioning system and guided catheter:
This article was originally published in Clinica
Executive Summary
MediGuide has CE marked its Medical Positioning System (MPS) and MPS-enabled Guided Measurement Catheter (GMC) for sale in Europe. The MPS is a navigation system designed to be used in various minimally-invasive procedures. When equipped on an X-ray imaging cath lab system, the MPS can aid the intravascular evaluation of coronary anatomy. It allows real-time tip positioning and navigation of a diagnostic or therapeutic invasive device (if equipped with an MPS sensor) for coronary or cardiac intervention. The GMC, also CE marked by the Haifa, Israel company, is the first MPS-enabled catheter. It is intended to be used in conjunction with conventional X-ray angiography systems equipped with MPS, to enable tip positioning and navigation, quantitative length measurement, 3D lumen reconstruction, qualitative 3D foreshortening indication and landmarking in patients who are candidates for coronary angiography and/or percutaneous coronary intervention.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.